Panel Discussion: Making Cell Therapy for Autoimmune Diseases a Commercial Reality

Time: 3:45 pm
day: Conference Day Two


  • What challenges do we expect to encounter on our way towards commercial approval (i.e., regulatory, manufacturing, pricing)?
  • With autoimmune diseases having larger patient population than oncology indications, how will we deal with the demand?
  • How do we overcome these challenges to ensure we get better cell therapies for patients in need, faster?